SE501548C2 - Isokinolinderivat, deras framställning och deras användning - Google Patents

Isokinolinderivat, deras framställning och deras användning

Info

Publication number
SE501548C2
SE501548C2 SE8900039A SE8900039A SE501548C2 SE 501548 C2 SE501548 C2 SE 501548C2 SE 8900039 A SE8900039 A SE 8900039A SE 8900039 A SE8900039 A SE 8900039A SE 501548 C2 SE501548 C2 SE 501548C2
Authority
SE
Sweden
Prior art keywords
dimethoxy
formula
hydrogen
dimethoxyphenyl
compound
Prior art date
Application number
SE8900039A
Other languages
English (en)
Swedish (sv)
Other versions
SE8900039D0 (sv
SE8900039L (sv
Inventor
Klaus Hasspacher
Reto Naef
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8900039D0 publication Critical patent/SE8900039D0/xx
Publication of SE8900039L publication Critical patent/SE8900039L/xx
Publication of SE501548C2 publication Critical patent/SE501548C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE8900039A 1988-01-08 1989-01-05 Isokinolinderivat, deras framställning och deras användning SE501548C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888800397A GB8800397D0 (en) 1988-01-08 1988-01-08 Improvements in/relating to organic compounds

Publications (3)

Publication Number Publication Date
SE8900039D0 SE8900039D0 (sv) 1989-01-05
SE8900039L SE8900039L (sv) 1989-07-09
SE501548C2 true SE501548C2 (sv) 1995-03-13

Family

ID=10629678

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8900039A SE501548C2 (sv) 1988-01-08 1989-01-05 Isokinolinderivat, deras framställning och deras användning

Country Status (28)

Country Link
US (1) US4980359A (fi)
JP (1) JPH0649686B2 (fi)
KR (1) KR0142686B1 (fi)
AT (1) AT394365B (fi)
AU (1) AU622429B2 (fi)
BE (1) BE1002730A3 (fi)
CA (1) CA1332944C (fi)
CH (1) CH678727A5 (fi)
DE (1) DE3900233C2 (fi)
DK (1) DK5789A (fi)
ES (1) ES2010071A6 (fi)
FI (1) FI90865C (fi)
FR (1) FR2625743B1 (fi)
GB (2) GB8800397D0 (fi)
GR (1) GR1002750B (fi)
HU (1) HU205083B (fi)
IE (1) IE61914B1 (fi)
IL (1) IL88899A (fi)
IT (1) IT1229523B (fi)
LU (1) LU87423A1 (fi)
MY (1) MY103963A (fi)
NL (1) NL8900029A (fi)
NZ (1) NZ227561A (fi)
PH (1) PH25640A (fi)
PL (1) PL156099B1 (fi)
PT (1) PT89405B (fi)
SE (1) SE501548C2 (fi)
ZA (1) ZA89133B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2723674A (en) * 1951-11-28 1955-11-15 Charles E Harris Telephone cableman's tent
US3007541A (en) * 1959-02-24 1961-11-07 Jr John B Mast Temporary covering and support structure therefor
GB8807922D0 (en) * 1988-04-05 1988-05-05 Fujisawa Pharmaceutical Co Isoquinoline compound & process for preparation thereof
US4956371A (en) * 1989-09-19 1990-09-11 Euroceltique, S.A. Substituted isoquinolines and methods of using same
GB8921304D0 (en) * 1989-09-20 1989-11-08 Wyeth John & Brother Ltd New method of treatment and heterocyclic compounds used therein
GB9027055D0 (en) * 1990-12-13 1991-02-06 Sandoz Ltd Organic compounds
EP0491441A1 (en) * 1990-12-17 1992-06-24 Shell Internationale Researchmaatschappij B.V. Fungicidal isoquinoline derivatives
CA2093577C (en) * 1992-05-07 2006-01-03 Michael Klaus Alkyl or alkoxy substituted s-heterocyclic retinoids
US5350423A (en) * 1992-09-23 1994-09-27 Burlington Industries Inc. Fabric finishing procedure
GB9322828D0 (en) * 1993-11-05 1993-12-22 Sandoz Ltd Organic compounds
US5683892A (en) * 1994-12-23 1997-11-04 Smithkline Beecham Corporation DNA encoding recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
US7399837B2 (en) * 1995-12-22 2008-07-15 Smithkline Beecham Corporation Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
DE69535319T2 (de) * 1994-12-23 2007-07-19 Smithkline Beecham Corp. Rekombinante il-5 antagonisten für die behandlung von il-5 bedingten krankheiten
US5783184A (en) * 1994-12-23 1998-07-21 Smithkline Beecham Corporation Method for treatment and diagnosis of IL-5 mediated disorders
GB9622386D0 (en) * 1996-10-28 1997-01-08 Sandoz Ltd Organic compounds
IT1296985B1 (it) * 1997-12-19 1999-08-03 Zambon Spa Derivati benzazinici inibitori della fosfodiesterasi 4
ATE356810T1 (de) * 1999-01-15 2007-04-15 Altana Pharma Ag Polysubstituted 6-phenylphenanthridines mit pde- iv hemmender wirkung
CA2381802C (en) 1999-08-21 2010-12-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of roflumilast and salmeterol
EA200501548A1 (ru) 2003-04-01 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. Ингибиторы фосфодиэстераз при бесплодии
EP2606906A1 (en) * 2007-04-30 2013-06-26 GlaxoSmithKline LLC Methods for administering anti-IL-5 antibodies
MX2010010667A (es) * 2008-03-28 2010-11-09 Glaxosmithkline Llc Metodos de tratamiento.
JP6265583B2 (ja) 2008-10-17 2018-01-24 ウィスコンシン アルムニ リサーチ ファンデイション 生理活性アルファベータペプチドを作製する方法
US11390671B2 (en) 2017-06-06 2022-07-19 Glaxosmithkline Llc Biopharmaceutical compositions and methods for pediatric patients

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB645139A (en) * 1946-10-22 1950-10-25 Servita Gyogyszeryar Es Vegyip Improved process for the production of isoquinoline derivatives
DE1184344B (de) * 1962-06-16 1964-12-31 Orgamol Sa Verfahren zur Herstellung von Isochinolinderivaten
US3878215A (en) * 1971-12-01 1975-04-15 Sandoz Ag 2-Alkyl-3-substituted-4-aryl isoquinolines
DE2401453A1 (de) * 1973-01-16 1974-07-18 John James Voorhees Pharmazeutische zusammensetzung zur behandlung von hautproliferationserkrankungen
US4018927A (en) * 1973-12-17 1977-04-19 The Regents Of The University Of Michigan Treatment of proliferating skin diseases with papaverine alkaloids
DK136189B (da) * 1974-02-05 1977-08-29 Sandoz Ag Analogifremgangsmåde til fremstilling af benzo(c)(1,6)naphthyridinderivater eller syreadditionssalte deraf.
DE2811361A1 (de) * 1978-03-16 1979-09-27 Hoechst Ag Neue isochinolinaldehyde und verfahren zu ihrer herstellung
DE3244594A1 (de) * 1982-12-02 1984-06-07 Hoechst Ag, 6230 Frankfurt 1-phenylisochinolinderivate und verfahren zu ihrer herstellung, diese verbindung enthaltende pharmazeutische praeparate und deren anwendung
HU196758B (en) * 1986-05-21 1989-01-30 Gyogyszerkutato Intezet Process for production of 3-hidroxi-methil-quinolines and medical compositions containing them
CA1330560C (en) * 1986-05-21 1994-07-05 Maurits E. A. Vandewalle Di- and tetrahydroisoquinoline derivatives

Also Published As

Publication number Publication date
FR2625743B1 (fr) 1990-11-09
PL277092A1 (en) 1989-09-04
IE61914B1 (en) 1994-11-30
BE1002730A3 (fr) 1991-05-21
PT89405B (pt) 1993-09-30
KR890011851A (ko) 1989-08-22
JPH01213267A (ja) 1989-08-28
NL8900029A (nl) 1989-08-01
IL88899A (en) 1994-07-31
DK5789D0 (da) 1989-01-06
US4980359A (en) 1990-12-25
KR0142686B1 (ko) 1998-07-15
DE3900233C2 (de) 2000-04-27
SE8900039D0 (sv) 1989-01-05
HUT52061A (en) 1990-06-28
IL88899A0 (en) 1989-08-15
CA1332944C (en) 1994-11-08
FI890072A0 (fi) 1989-01-06
GB8800397D0 (en) 1988-02-10
GB8900102D0 (en) 1989-03-01
MY103963A (en) 1993-10-30
FI90865C (fi) 1994-04-11
ZA89133B (en) 1990-09-26
IT1229523B (it) 1991-09-04
JPH0649686B2 (ja) 1994-06-29
GB2213482A (en) 1989-08-16
DE3900233A1 (de) 1989-07-20
GB2213482B (en) 1991-09-11
PT89405A (pt) 1990-02-08
LU87423A1 (fr) 1989-08-30
PL156099B1 (pl) 1992-02-28
FR2625743A1 (fr) 1989-07-13
GR890100008A (el) 1994-03-31
IT8947504A0 (it) 1989-01-04
PH25640A (en) 1991-08-21
SE8900039L (sv) 1989-07-09
DK5789A (da) 1989-07-09
NZ227561A (en) 1991-11-26
ATA3589A (de) 1991-09-15
AU2779589A (en) 1989-07-20
AT394365B (de) 1992-03-25
GR1002750B (el) 1997-08-26
ES2010071A6 (es) 1989-10-16
CH678727A5 (fi) 1991-10-31
FI90865B (fi) 1993-12-31
HU205083B (en) 1992-03-30
IE890037L (en) 1989-07-08
AU622429B2 (en) 1992-04-09
FI890072A (fi) 1989-07-09

Similar Documents

Publication Publication Date Title
SE501548C2 (sv) Isokinolinderivat, deras framställning och deras användning
US5177085A (en) Dihydro-isoquinoline derivatives, processes for their production, pharmaceutical compositions containing them, and their use in treating asthma
DK169337B1 (da) Xanthinforbindelser, farmaceutisk præparat indeholdende disse, xanthinforbindelser til anvendelse som et farmaceutisk middel samt fremgangsmåde til fremstilling af forbindelserne
US5905156A (en) Benzopyrans and pharmaceutical compositions containing them
US4791121A (en) 4-phenyl-4-(N-(phenyl)amido) piperidine derivatives and pharmaceutical compositions and method employing such compounds
US5574049A (en) 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans
WO1994012493A1 (en) 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2h-1-benzopyr ans, their use as pharmaceuticals
EP0435235A1 (en) Isoquinoline derivatives and salts thereof as protease inhibitors.
EP0035819A1 (en) Quinoline derivatives, pharmaceutical compositions containing such compounds, and methods for the preparation of these compounds
JPH03294277A (ja) ピペリジン誘導体
JPH02135A (ja) 多還式化合物とこれを含有する医薬組成物
AU665040B2 (en) 4-carboxamido-6(pyridin-4-yl substituted benzopyran derivatives
JPH0859654A (ja) 中枢神経系治療用薬剤としての６−アミノ−１，４−ジヒドロピリジン類の使用およびそれらの製造方法
MXPA97009004A (en) Benzopira
PL154160B1 (pl) Sposób wytwarzania nowych pochodnych ksantyny